Common Stock Reserved For Issuance

6 Months Ended

Jun. 30, 2019

Equity [Abstract]

Common Stock Reserved For Issuance

10. COMMON STOCK RESERVED FOR ISSUANCE

Common stock has been reserved for the following potential future issuances:

	As of June 30, 2019		As of December 31, 2018
Shares underlying outstanding stock options		588,737		405,683
Shares available for future stock option grants		239,946		423,000
Exchange of Vaccinex Products, LP units		1,198,111		1,202,566
Conversion of VX3 units		1,318,797		1,318,797
Total shares of common stock reserved		3,345,591		3,350,046

During the three months ended June 30, 2019 4,455 units of Vaccinex Products, LP were converted to common shares of Vaccinex, Inc. at par value of $.0001 per share.